MAY 10, 2018 01:49 PM PDT

New Biomarker for Lung Cancer Diagnosis

WRITTEN BY: Kara Marker

Lung cancer is the most common cause of death from cancer for both genders and for people all over the globe. This is largely due to the lack of diagnostic markers that indicate early stages of cancer. But now, scientists from a new Japan study introduce a biomarker that could drastically change cancer diagnostics and treatment: CKAP4.

Histopathology of small cell lung carcinoma. Credit: Yale Rosen

There are several existing biomarkers that scientists use to diagnose lung cancer:

  • Carcinoma embryonic antigen (CEA)
  • Sialyl Lewis X antigen (SLX)
  • Squamous cell carcinoma (SCC) antigen
  • Cytokeratin fragment (CYFRA) 21-1

But none of them are sensitive enough to detect lung cancer in its early stages, and this is a huge problem for diagnosis, prognosis, and treatment of patients affected.

In the new study, researchers used several lab techniques to test a monoclonal antibody called KU-Lu-1. A monoclonal antibody is a lab-derived protein that binds to other proteins in the body. In this case, KU-Lu-1 only targeted tumor cells from lung cancer tissues, not normal lung tissues. Researchers first tested KU-Lu-1 in blood samples from 271 different lung cancer patients and 100 healthy individuals.

After confirming that KU-Lu-1 only targeted cancerous tissue, researchers observed that KU-Lu-1 targets lung cancer cells by recognizing cytoskeleton-associated protein 4 (CKAP4).

"The results of our study provide evidence that the CKAP4 protein may be a novel early sero-diagnostic marker for lung cancer,” explained co-investigator Ryo Nagashio, PhD.

"The use of CKAP4 as a biomarker could change current practices regarding the treatment of lung cancer patients, and the diagnostic accuracies may be markedly improved by the combination of CKAP4 and conventional markers," explained study leader Yuichi Sato, PhD.

CKAP4 is a receptor of another protein called Dickkopf1 (DKK1). When both of these proteins are expressed, prognosis worsens and the chance of relapse-free survival for lung cancer patients minimizes.

"The identification of patients at an early stage of cancer when it can be treated surgically is extremely important to improve prognosis," Sato concluded. "We need better biomarkers for early diagnosis."

The present study was published in the American Journal of Pathology.

Sources: Elsevier, National Cancer Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 31, 2018
Immunology
MAY 31, 2018
Immunosuppressant Drugs to Prevent Parkinson's Disease
Certain immune activity could be increasing a person’s risk of developing Parkinson’s disease (PD), but immunosuppressant drugs might solve the...
JUN 22, 2018
Health & Medicine
JUN 22, 2018
A New Test for Peanut Allergy: Better, Faster, Cheaper.
Scientists from the Medical Research Council (MRC) in the UK have come up with a test to detect peanut allergies and it’s safer, quicker and more acc...
JUL 11, 2018
Immunology
JUL 11, 2018
The Power of Seal Serum
Unlike humans, seals remain uninjured despite repeated deep dives to hunt. Scientists have shown that serum from seals blood provides anti-inflammatory properties that lower immune response....
JUL 16, 2018
Immunology
JUL 16, 2018
T cells and the Need for Speed
A recent study has shown that T cell receptors are dispersed across the T cell surface, as opposed to clustered, to allow for a rapid immune reaction....
AUG 22, 2018
Immunology
AUG 22, 2018
Immune Response Runs on the Body Clock
Immune cell functions such as inflammation are dictated by your bodies circadian rhythm, responding daily to external stimuli on a 24 hour schedule....
SEP 14, 2018
Immunology
SEP 14, 2018
Zika Strong Arms the Immune System
Zika Virus manipulates the genetic makeup of immune cells called macrophages....
Loading Comments...